However, GLP-1-based therapies aren't going to be the only option in the weight loss medicines market forever. Some companies ...

Popular weight loss drugs are so pricey that many may shell out hundreds or even thousands of dollars on them. Some ...

Zealand Pharma CEO Adam Steensberg said Friday that the company is working on a next-generation weight loss drug that’s ...

If Medicare were to start covering popular weight loss drugs such as Wegovy and Zepbound, it could increase federal spending ...

Some patients fear that they’ll lose access to tirzepatide because the US Food and Drug Administration determined that a ...

Meanwhile, cities in New Mexico, Minnesota, Kansas, and Utah are leading the pack for cities who are the most open to trying ...

Fewer than 20% of large employers are covering GLP-1 weight loss drugs like Ozempic, a new KFF analysis shows.

Only a fifth of large U.S. companies cover pricey GLP-1 weight-loss drugs like Wegovy and Zepbound in their health insurance ...

Expanding Medicare to cover weight loss drugs would cost $35 billion over eight years, according to a new report from the ...

Less than a fifth of large employers in the U.S. include coverage for the popular but pricey weight loss drugs Wegovy and ...

She would have periods in time where she’d suddenly wake up in the middle of the day and she couldn’t remember anything from ...

Just like when you find a glitzy resort in your dream destination, your first question about weight loss drugs might be, how ...